Rosenblum Silverman Sutton’s Aclaris Therapeutics ACRS Stock Holding History

Rosenblum Silverman Sutton’s Portfolio ACRS Stock Details ACRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell
2018 Q4	$429K	Sell
2018 Q3	$1.3M	Buy
2018 Q2	$1.48M	Buy
2018 Q1	$774K	Sell
2017 Q4	$1.14M	Buy
2017 Q3	$1.07M	Buy
2017 Q2	$1.04M	Buy
2017 Q1	$977K	Buy
2016 Q4	$574K	Buy